Regeneron and Bayer Strengthen Eylea's Retinal Vein Occlusion Position Amid Growing Biosimilar Challenges

Regeneron and Bayer Strengthen Eylea’s Retinal Vein Occlusion Position Amid Growing Biosimilar Challenges